Carcinoma: all 6,718 studies
Page 48 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT02659241Early Phase 1
- Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsCompletedNCT02658214Phase 1
- TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsTerminatedNCT02650635Phase 1
- Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCCCompletedNCT02650271Phase 3
- Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary ObstructionCompletedNCT02649712Not applicable
- A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell CarcinomaWithdrawnNCT02649530Phase 2
- Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)CompletedNCT02649361Phase 2
- Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary CarcinomaStatus unknownNCT02648399Not applicable
- A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCCCompletedNCT02647125Phase 2
- Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsCompletedNCT02646319Early Phase 1
- Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell CarcinomaCompletedNCT02645864Phase 1
- Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With ChemoradiotherapyCompletedNCT02644408Phase 3
- Hepatocellular Carcinoma Recurrence and AnesthesiaCompletedNCT02643173
- Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma PatientsCompletedNCT02642913Phase 1
- Individualized Elective Neck Irradiation Based on MRI in NPC PatientsCompletedNCT02642107Phase 3
- Proton Radiotherapy Versus Radiofrequency Ablation for Patients With Medium or Large Hepatocellular CarcinomaStatus unknownNCT02640924Phase 3
- Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCCStatus unknownNCT02639858Phase 2
- Photodynamic Therapy and Vismodegib for Multiple Basal Cell CarcinomasCompletedNCT02639117Phase 1
- Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT02638857Phase 1/2
- Endostar for Locally Recurrent Nasopharyngeal CarcinomaStatus unknownNCT02636231Phase 2
- Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02633176Phase 3
- Immunotherapy Using Pluripotent Killer-Programmed Cell Death 1 (PIK-PD-1) Cells for the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT02632006Phase 1/2
- Efficacy Study of TACE to Treat Hepatocellular Carcinoma After OperationStatus unknownNCT02631499Phase 4
- TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular CarcinomaStatus unknownNCT02630108Phase 3
- Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac CancerStatus unknownNCT02628665Phase 3
- Safety Study of MGD009 in B7-H3-expressing TumorsTerminatedNCT02628535Phase 1
- Outcomes of FoundationOne Directed Therapy in Cancer of Unknown PrimaryCompletedNCT02628379
- Atovaquone as Tumour HypOxia ModifierCompletedNCT02628080Early Phase 1
- Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal CarcinomaStatus unknownNCT02627807Not applicable
- Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast CancerWithdrawnNCT02627430Phase 1
- A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian PopulationTerminatedNCT02626754Phase 2
- Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney CancerCompletedNCT02626130Early Phase 1
- Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & NeckWithdrawnNCT02624999Phase 2
- A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic CarcinomaCompletedNCT02623127Phase 2
- Reflectance Confocal Microscopy in Basal Cell CarcinomaCompletedNCT02623101Not applicable
- Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal CarcinomaStatus unknownNCT02621970Phase 3
- CAR-T Cell Immunotherapy in MUC1 Positive Solid TumorStatus unknownNCT02617134Phase 1/2
- Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular CarcinomaStatus unknownNCT02616926Not applicable
- Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid CarcinomaCompletedNCT02614495Phase 2
- Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular CarcinomaCompletedNCT02613156
- Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell CarcinomaStatus unknownNCT02611700Phase 3
- Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer SurvivorsCompletedNCT02611544Not applicable
- Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron InjectionWithdrawnNCT02610920Early Phase 1
- Chemoprevention of Head and Neck Squamous Cell Carcinoma (HNSCC) With Valproic AcidCompletedNCT02608736Early Phase 1
- A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial CarcinomaTerminatedNCT02608125Phase 1
- A Prospective, Observational Trial on the Diagnostic and Prognostic of LMStatus unknownNCT02607605
- Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMACompletedNCT02607553Phase 2
- Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous CancerStatus unknownNCT02607540Phase 3
- Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.CompletedNCT02606916Phase 2
- Temozolomide in Preventing Brain Metastases in Small Cell Lung CancerStatus unknownNCT02605811Phase 2
- Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancer and Primary Peritoneal TumorsCompletedNCT02604784Phase 1/2
- Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma PatientsCompletedNCT02604472
- Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent ChemoradiotherapyStatus unknownNCT02603159Phase 3
- Gut Microbiota in People With Hepatocellular Carcinoma (HCC)WithdrawnNCT02599909
- Nivolumab in Treating Patients With High-Risk Kidney Cancer Before SurgeryTerminatedNCT02595918Phase 1
- MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLCCompletedNCT02592577Phase 1
- Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine CancerCompletedNCT02592356Not applicable
- Different Dose of Methotrexate for the Treatment of Meningeal CarcinomatosisStatus unknownNCT02590510Phase 4
- A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPCStatus unknownNCT02590133Phase 2
- Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown PrimaryStatus unknownNCT02590055Phase 2
- An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing ChemotherapyApproved for marketingNCT02589717
- Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPHStatus unknownNCT02587884Phase 1
- Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid TumorStatus unknownNCT02587689Phase 1/2
- Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of EsophagusStatus unknownNCT02586753Phase 2
- Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)CompletedNCT02586350Phase 2/3
- Dose-escalating AZD1775 + Concurrent Radiation + Cisplatin for Intermediate/High Risk HNSCCCompletedNCT02585973Phase 1
- Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular CarcinomaTerminatedNCT02585687Not applicable
- Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular CarcinomaWithdrawnNCT02585479Phase 2/3
- Whey Protein Supplement in Combination With Physical Exercise and Nutrition ProgramCompletedNCT02585362Not applicable
- Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular CarcinomaWithdrawnNCT02584556Phase 2/3
- Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)Active, not recruitingNCT02584478Phase 3
- REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological ProgressionCompletedNCT02584465Phase 2
- Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5CompletedNCT02582918Not applicable
- Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without ChemotherapyTerminatedNCT02582008Early Phase 1
- Clinical Study of Effectiveness of Radiotherapy Before Surgery in High-risk Relapse Hepatocellular Cancer PatientsStatus unknownNCT02580929Not applicable
- Utility of the Skin Cancer Quality of Life Impact ToolCompletedNCT02580916Not applicable
- Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver TransplantationWithdrawnNCT02580253Phase 2
- Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing SurgeryCompletedNCT02579551Not applicable
- Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic MalignanciesCompletedNCT02578888Not applicable
- MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver CancerCompletedNCT02578602Phase 1
- Study of the Combination of CM082 With Everolimus in Patients With mRCCStatus unknownNCT02577458Phase 1
- A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver CancerCompletedNCT02576964Phase 2
- The Role of Melanocyte in Basal Cell CarcinomaStatus unknownNCT02576769
- Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of LumpectomyCompletedNCT02576106Not applicable
- Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC PatientsCompletedNCT02575547
- GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer PatientsCompletedNCT02575404Phase 1
- Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell CarcinomaCompletedNCT02575222Phase 1
- Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS TumorsActive, not recruitingNCT02574728Phase 2
- Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF TherapyTerminatedNCT02570789Phase 4
- Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal CarcinomaTerminatedNCT02569788Phase 1/2
- Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionWithdrawnNCT02567396Phase 1
- ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid TumorsCompletedNCT02565758Phase 1
- The Effect of Telephone Counseling on the Compliance and Satisfaction for Advanced HCC Patients Receiving SorafenibStatus unknownNCT02564666Not applicable
- A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult Participants With Hepatocellular Carcinoma (HCC)CompletedNCT02564614Phase 1
- Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-CisplatinCompletedNCT02562599Phase 2
- Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal CancerActive, not recruitingNCT02560298Phase 2
- Correlation Between CT Perfusion and Post Y-90 TARE PET/CT DosimetryWithdrawnNCT02558205
- Randomized Control Trial (RCT) of Early Palliative Care for HCCStatus unknownNCT02556619Not applicable
- Low-Carbohydrate Normocaloric Diet in Patients With Head and Neck Carcinoma (HNC)CompletedNCT02555176Not applicable
- Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial ChemoembolizationCompletedNCT02552745